Fernando Pagan, MD
Enriched profileProfessor and Vice Chair of Neurology · MedStar Georgetown University Hospital
Fernando Pagan is Professor and Vice Chair of Neurology at MedStar Georgetown University Hospital. OpenAlex indexes 144 publications with 2,775 citations (h-index 27); ClinicalTrials.gov lists 9 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 14 Oct 2026
Fernando L. Pagan is Professor and Vice Chair of Neurology at MedStar Georgetown University Hospital. The public record shows 144 publications with 2,775 citations (h-index 27), centered on Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Botulinum Toxin and Related Neurological Disorders. It also documents an investigator role on 9 registered clinical trials, industry payments reported by 34 companies.
- Most recent indexed publication: 2024 · CNS drugs
- Top research focus: Parkinson's Disease Mechanisms and Treatments
- 9 registered trials on ClinicalTrials.gov
- Open Payments reporting from 34 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 1 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 46.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:
- RESvEraTrol in Parkinson's Disease (RESET)
Sponsor: Georgetown University
- Istradefylline Effect Protocol on Parkinson's Disease Tremor
Sponsor: Georgetown University
- Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Dementia With Lewy Bodies
Sponsor: Georgetown University
Industry payments
Updated 14 Oct 2026
34 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Amneal Pharmaceuticals LLCProgram year202521 payments$31,239openpaymentsdata.cms.gov ↗
- MDD US Operations, LLCProgram year202529 payments$18,997openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year202531 payments$10,374openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
99.2%Neuromuscular Blocker99.2%Onabotulinumtoxina64%Incobotulinumtoxin a36%Part B, office-administered≥35 patientsNervous system
0.7%Aromatic Amino Acid Decarboxylation Inhibitor0.2%Rytary100%Part D≥14 patientsBenzodiazepine0.2%Clonazepam100%Part D≥35 patients+ 4 more classes in this area
Hormonal (systemic)
0%Mineralocorticoids0%Fludrocortisone Acetate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 14 Oct 2026
1 congress contribution (2017) across AMCP per OpenAlex. The most recent:
- The Emerging Role of Pimavanserin in the Management of Parkinson’s Disease Psychosis
AMCP Meeting
AMCP2017Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
Most-cited works
by citation count (OpenAlex)- 01
- 02
- 05SIAXI121 citations2019
Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 14 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/fernando-pagan-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/fernando-pagan-md-faan-b80980209
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/scientific-contributions/Fernando-Pagan-37900002
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- LinkedIn
LinkedIn: Fernando Pagan, MD, FAAN
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medstarhealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medstarhealth.org ↗
Editorial & leadership roles
journal and society appointments- Vice Chair
Department of Neurology, MedStar Georgetown University Hospital
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗ - Director
Movement Disorders Program, MedStar Georgetown University Hospital
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →neurology.georgetown.edu ↗ - Medical Director
MedStar Georgetown National Parkinson Foundation Center of Excellence
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →neurology.georgetown.edu ↗ - Medical Director
Translational Neurotherapeutics Program, MedStar Georgetown University Hospital
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →neurology.georgetown.edu ↗ - Fellowship Director
Movement Disorders Fellowship, MedStar Georgetown University Hospital
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medstarhealth.org ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
Secondary affiliations
appointments beyond the home institution- MedStar Georgetown University Hospital - McLean
VA satellite clinic location (Neurology, Movement Disorders)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medstarhealth.org ↗
Media & interviews
press, podcasts and appearances- NeurologyLive contributor/interviewee
recurring expert commentary on Parkinson's disease and movement disorder therapeutics
2025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →neurologylive.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medstarhealth.org ↗
- "What's in my white coat with Fernando Pagan"
Georgetown Today magazine feature profile
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →today.advancement.georgetown.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Hagop Kantarjian, MD
The University of Texas MD Anderson Cancer Center
Jorge Cortes, MD
University of Alabama at Birmingham (UAB)
Ayalew Tefferi, MD
Mayo Clinic
Charles Sawyers, MD
Memorial Sloan Kettering Cancer Center